XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Product Information [Line Items]          
Cash FDIC insurance $ 250,000   $ 250,000   $ 500,000
Patent and licensing legal and filing fees and costs $ 358,389 $ 108,193 $ 673,626 $ 228,352  
Revenue Benchmark [Member] | Product Concentration Risk [Member] | General and Administrative Expense [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 26.00% 7.40% 29.00% 8.30%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor One [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 29.70% 26.00% 44.60% 43.80%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Two [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 18.20% 16.30% 16.50% 19.70%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Three [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 17.40% 11.40%      
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Four [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 12.60%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Research and Development Expense [Member] | Vendor Five [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 10.20%